Sg Americas Securities, LLC Harmony Biosciences Holdings, Inc. Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 22,498 shares of HRMY stock, worth $774,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,498
Previous 15,724 43.08%
Holding current value
$774,606
Previous $629,000 23.05%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$31.86 - $41.49 $215,819 - $281,053
6,774 Added 43.08%
22,498 $774,000
Q3 2024

Oct 03, 2024
BUY
$30.0 - $39.95 $334,740 - $445,762
11,158 Added 244.37%
15,724 $629,000
Q2 2024

Jul 12, 2024
BUY
$28.81 - $33.01 $131,546 - $150,723
4,566 New
4,566 $138,000
Q4 2023

Jan 12, 2024
SELL
$19.2 - $33.78 $219,033 - $385,362
-11,408 Reduced 56.05%
8,945 $289,000
Q3 2023

Oct 13, 2023
BUY
$31.89 - $39.03 $649,057 - $794,377
20,353 New
20,353 $667,000
Q4 2022

Feb 02, 2023
BUY
$45.4 - $60.91 $121,445 - $162,934
2,675 New
2,675 $147,000
Q2 2022

Jul 29, 2022
BUY
$33.54 - $52.15 $226,763 - $352,586
6,761 Added 62.23%
17,626 $860,000
Q1 2022

Apr 29, 2022
SELL
$33.14 - $51.13 $237,481 - $366,397
-7,166 Reduced 39.74%
10,865 $529,000
Q4 2021

Feb 07, 2022
BUY
$34.09 - $43.91 $334,934 - $431,415
9,825 Added 119.73%
18,031 $769,000
Q3 2021

Nov 01, 2021
BUY
$25.68 - $38.61 $210,730 - $316,833
8,206 New
8,206 $315,000

Others Institutions Holding HRMY

# of Institutions
255
Shares Held
46.7M
Call Options Held
119K
Put Options Held
50K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.04B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email